Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 11, 1991
Intraperitoneal cisplatin and cytarabine in the treatment of refractory or recurrent ovarian carcinomaM Markman, T Hakes, B Reichman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 11, 1992
Impact on survival of surgically defined favorable responses to salvage intraperitoneal chemotherapy in small-volume residual ovarian cancerM Markman, B Reichman, T Hakes, et al.
Seminars in Oncology|December 11, 1992
Exploring the use of chronic low-dose oral etoposide in ovarian cancer: is there a role for this "new drug" in the management of platinum-refractory disease?M Markman, T Hakes, B Reichman, et al.
Journal of Cancer Research and Clinical Oncology|January 11, 1992
Association between pretreatment CA-125 levels and surgically documented complete responses in patients with ovarian cancer treated with second-line intraperitoneal therapyM Markman, B Reichman, T Hakes, et al.
Journal of Cancer Research and Clinical Oncology|January 11, 1992
Phase 2 trial of chronic low-dose oral etoposide as salvage therapy of platinum-refractory ovarian cancerM Markman, T Hakes, B Reichman, et al.
Cancer|January 15, 1993
Epithelial ovarian cancer in the elderly. The Memorial Sloan-Kettering Cancer Center experienceM Markman, J L Lewis, P Saigo, et al.
Gynecologic Oncology|July 1, 1993
Evidence supporting the superiority of intraperitoneal cisplatin compared to intraperitoneal carboplatin for salvage therapy of small-volume residual ovarian cancerM Markman, B Reichman, T Hakes, et al.
Gynecologic Oncology|June 11, 1992
Randomized prospective trial of 5 versus 10 cycles of cyclophosphamide, doxorubicin, and cisplatin in advanced ovarian carcinomaT B Hakes, E Chalas, W J Hoskins, et al.
Gynecologic Oncology|September 1, 1989
Influence of secondary cytoreduction at the time of second-look laparotomy on the survival of patients with epithelial ovarian carcinomaW J Hoskins, S C Rubin, E Dulaney, et al.
Gynecologic Oncology|August 11, 1991
Prognostic factors for recurrence following negative second-look laparotomy in ovarian cancer patients treated with platinum-based chemotherapyS C Rubin, W J Hoskins, P E Saigo, et al.
Pageof 5